Cancer Therapy: Biotransporting Self‐Assembled Nanofactories Using Polymer Vesicles with Molecular Permeability for Enzyme Prodrug Cancer Therapy (Adv. Mater. 36/2017)
Source abstract
Abstract
In article number 1702406, Kazunari Akiyoshi and co-workers develop self-assembled nanofactories formulated with intrinsically molecular permeable polymer vesicles. Because of this permeability, enzyme-loaded vesicles act as enzyme reactors, enabling the diffusion of a variety of low-molecular-weight substrates, including clinical prodrugs, to react with the retained encapsulated enzymes in vitro and in vivo. Thus, the vesicles serve as nanofactories that can transform prodrugs into drugs at tumor sites for cancer therapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Supramolecular Self-Assembly in Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Polymer Chemistry Graduate School of Engineering Kyoto University Katsura Nishikyo‐ku Kyoto 615‐8510 Japan
ERATO Bio‐nanotransporter Project Japan Science and Technology Agency (JST) Kyoto University Katsura Nishikyo‐ku Kyoto 615‐8530 Japan
References
Reference metadata was not supplied for this record.